Veradermics Inc.

05/05/2026 | Press release | Distributed by Public on 05/05/2026 17:42

Initial Statement of Beneficial Ownership (Form 3)

FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Seven Fleet Capital Management LP
2. Date of Event Requiring Statement (Month/Day/Year)
05/01/2026
3. Issuer Name and Ticker or Trading Symbol
Veradermics, Inc [MANE]
(Last) (First) (Middle)
960 SAN CLEMENTE WAY
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)
MOUNTAIN VIEW, CA 94043
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, $0.00001 par value per share 80,000 I(1) By Managed Funds(1)
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Seven Fleet Capital Management LP
960 SAN CLEMENTE WAY
MOUNTAIN VIEW, CA 94043
X

Signatures

Seven Fleet Master Fund LP By: Seven Fleet Capital Management LP, its Investment Manager By: Seven Fleet Capital Management GP, LLC, its General Partner /s/ Dr. Brian Liu Managing Member 05/05/2026
**Signature of Reporting Person Date
Seven Fleet Capital Management LP By: Seven Fleet Capital Management GP, LLC, its General Partner /s/ Dr. Brian Liu Managing Member 05/05/2026
**Signature of Reporting Person Date
Seven Fleet Capital Management GP LLC /s/ Dr. Brian Liu Managing Member 05/05/2026
**Signature of Reporting Person Date
Brian Guan-Chyun Liu /s/ Dr. Brian Liu Managing Member 05/05/2026
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) This Form 3 is being filed by Seven Fleet Master Fund LP, a limited partnership organized under the laws of the Cayman Islands ("Seven Fleet Master Fund"), Seven Fleet Capital Management LP, a limited partnership organized under the laws of the State of Delaware ("Seven Fleet Management"), Seven Fleet Capital Management GP LLC, a limited liability company organized under the laws of the State of Delaware ("Seven Fleet Management GP" and together with Seven Fleet Master Fund and Seven Fleet Management, the "Reporting Entities") and Dr. Brian Liu. Dr. Liu may be deemed to control the Reporting Entities and therefore may be deemed to beneficially own shares of Common Stock held by the Reporting Entities. Dr. Liu disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of any indirect pecuniary interest therein.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Veradermics Inc. published this content on May 05, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on May 05, 2026 at 23:42 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]